 |
Press Releases
CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)-- AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that the deadline for political subdivisions in participating states to join the previously announced proposed opioid settlement agreement has been extended from January 2, 2022 to January 26, 2022. Additionally, the state of New Mexico has confirmed its intent to sign on the agreement, increasing the number of participating states as of December 22, 2021, to 43 out of 49 states, all 5 U.S. territories and Washington, D.C. Participation in the settlement process will expedite the delivery of meaningful relief to affected communities and allow the companies to focus their attention and resources on the safe and secure delivery of medications and therapies nationwide.
Consistent with the process laid out in the proposed settlement agreement, after the conclusion of the political subdivision sign-on period, participating states have an opportunity to determine whether there is sufficient participation in the settlement by political subdivisions to proceed to implementation. Following the notice from the participating states, each company will independently determine whether a sufficient number of political subdivisions have joined for the settlement to proceed to implementation. The deadline for that decision has been extended from February 1, 2022 to February 25, 2022.
The distributors remain deeply concerned about the impact the opioid epidemic is having on communities across the nation and remain committed to being part of the solution.
Cautionary Statements Regarding Forward Looking Statements
The preceding descriptions of a potential resolution of certain governmental entities’ opioids-related claims against pharmaceutical distribution companies constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that involve risks and uncertainties that could cause actual results to differ materially from those in those statements. It is not possible to identify all such risks and uncertainties. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, the companies undertake no obligation to publicly update forward-looking statements. Risk factors include, but are not limited to: the settlement process may not result in a resolution of all or any claims against each company regarding its role in distributing opioids; the companies may continue to experience costly and disruptive legal disputes and settlements related to distribution of controlled substances, including opioids; the companies might experience losses not covered by insurance; and the companies might be adversely impacted by changes in tax legislation or challenges to their respective tax positions. Investors should read the important risk factors described in each company’s Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange Commission.
About AmerisourceBergen
AmerisourceBergen fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies and providers, we create unparalleled access, efficiency and reliability for human and animal health. Our 42,000 global team members power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #8 on the Fortune 500 with more than $200 billion in annual revenue. Learn more at investor.amerisourcebergen.com.
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in more than 35 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.
About McKesson Corporation
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful - all for the better health of patients. McKesson has been named a “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit www.mckesson.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211222005587/en/
AmerisourceBergen
Investor Contact:
Bennett S. Murphy
610-727-3693
bmurphy@amerisourcebergen.com
Media Contact:
Gabe Weissman
610-727-3696
gweissman@amerisourcebergen.com
Cardinal Health
Investor Contact:
Kevin Moran
614-757-7942
kevin.moran@cardinalhealth.com
Media Contact:
Erich Timmerman
614-757-8231 erich.timmerman@cardinalhealth.com
McKesson
Investor Contact:
Rachel Rodriguez
469.260.0566
Rachel.Rodriguez@McKesson.com
Media Contact:
Sunny Rodriguez
972.589.4307
Sunny.Rodriguez@McKesson.com